Management

Day-to-day operations of the company are managed by the Senior Management Group under the direction of the Chief Executive Officer.

Chief Executive Officer	Mr David Lind
Commercialisation Director	Mr David Lind
Business Services Manager	Ms Kathy Rod
Research Director, Genome Program	Professor Robert Henry
Research Director, Applications Program	Dr Ken Quail
Education Director	Dr Nicole Rice
BioMolecular Processing Technology Platform Leader	Professor Robert Henry
BioProcessing Technology Platform Leader	Dr Michael Southan
Health Technology Platform Leader	Dr Ken Quail
Genome Program Coordinator	Dr Agnelo Furtado